1-5 of 5
Frederick R. Appelbaum, M.D.
Close
Sort by
Journal Articles

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Fabiana Ostronoff, MD, Barry Storer, PhD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J. Martin, MD, Frederick R. Appelbaum, M.D., David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, MSc
Journal: Blood
Blood (2011) 118 (21): 665.
https://doi.org/10.1182/blood.V118.21.665.665
Published: 2011
Journal Articles

Late Relapses Following All-Trans Retinoic Acid for Acute Promyelocytic Leukemia Are Uncommon, Respond Well to Salvage Therapy and Occur Independently of Prognostic Factors At Diagnosis: Long-Term Follow-up of North American Intergroup Study I0129

Dan Douer, MD, Lynette Zickl, M.S., Charles A. Schiffer, M.D., Frederick R. Appelbaum, M.D., James H. Feusner, M.D., Lois E Shepherd, M.D., Cheryl L Willman, MD, Clara D. Bloomfield, MD, Jacob M. Rowe, MD, Peter H. Wiernik, M.D., Martin S. Tallman, MD
Journal: Blood
Blood (2011) 118 (21): 83.
https://doi.org/10.1182/blood.V118.21.83.83
Published: 2011
Journal Articles

Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not

Ravinder K Sandhu, Jack M. Lionberger, MD, PhD, Megan Othus, PhD, John M. Pagel, MD, PhD, Kathleen ShannonDorcy, RN, PhD, Paul C. Hendrie, MD, PhD, Stephen H. Petersdorf, MD, Pamela S Becker, MD, PhD, Frederick R. Appelbaum, M.D., Elihu H Estey, MD
Journal: Blood
Blood (2011) 118 (21): 1497.
https://doi.org/10.1182/blood.V118.21.1497.1497
Published: 2011
Journal Articles

A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables.

Boglarka Gyurkocza, M.D., Rainer Storb, M.D., Barry E. Storer, Ph., D., Thomas Chauncey, MD, Thoralf Lange, M.D., Ginna G. Laport, MD, Amelia Langston, M.D., Michael A. Pulsipher, M.D., Christopher Bredeson, M.D., Richard Maziarz, M.D., Benedetto Bruno, M.D., Finn Petersen, M.D., Michael Maris, M.D., Edward Agura, M.D., Andrew M. Yeager, M.D., Wolfgang A. Bethge, M.D., Firoozeh Sahebi, M.D., Frederick R. Appelbaum, M.D., David G. Maloney, M.D., Elihu H. Estey, M.D., Brenda M. Sandmaier, MD
Journal: Blood
Blood (2010) 116 (21): 3450.
https://doi.org/10.1182/blood.V116.21.3450.3450
Published: 2010
Journal Articles

Frequent PML-RAR α Mutations in Relapse Patients on Acute Promyelocytic Leukemia (APL) Intergroup Phase III Trial C9710.

Robert E. Gallagher, MD, Esther L. Schachter-Tokarz, B.A., Barry K. Moser, Ph.D., Dorie Sher, B.A., Elisabeth Paietta, Ph.D., Martin S. Tallman, M.D., Clara D. Bloomfield, M.D., Bayard L. Powell, M.D., Richard A. Larson, M.D., Frederick R. Appelbaum, M.D., Cheryl L. Willman, M.D., Richard C. Harvey, Ph.D., Wendy Stock, M.D.
Journal: Blood
Blood (2006) 108 (11): 2342.
https://doi.org/10.1182/blood.V108.11.2342.2342
Published: 2006